MENU
+Compare
ELV
Stock ticker: NYSE
AS OF
Oct 7, 12:29 PM (EDT)
Price
$355.41
Change
+$5.47 (+1.56%)
Capitalization
78.8B

ELV Elevance Health Forecast, Technical & Fundamental Analysis

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025... Show more

ELV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ELV with price predictions
Oct 06, 2025

ELV in upward trend: 10-day moving average moved above 50-day moving average on September 05, 2025

The 10-day moving average for ELV crossed bullishly above the 50-day moving average on September 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 18, 2025. You may want to consider a long position or call options on ELV as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ELV just turned positive on September 18, 2025. Looking at past instances where ELV's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

ELV moved above its 50-day moving average on September 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELV advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 206 cases where ELV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ELV broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.802) is normal, around the industry mean (4.250). P/E Ratio (14.847) is within average values for comparable stocks, (17.355). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (0.949). Dividend Yield (0.019) settles around the average of (0.022) among similar stocks. P/S Ratio (0.424) is also within normal values, averaging (0.663).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ELV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ELV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ELV is expected to report earnings to fall 41.29% to $5.19 per share on October 21

Elevance Health ELV Stock Earnings Reports
Q3'25
Est.
$5.19
Q2'25
Missed
by $0.23
Q1'25
Beat
by $0.89
Q4'24
Missed
by $0.14
Q3'24
Missed
by $1.29
The last earnings report on July 17 showed earnings per share of $8.84, missing the estimate of $9.07. With 143.38K shares outstanding, the current market capitalization sits at 78.80B.
A.I.Advisor
published Dividends

ELV paid dividends on September 25, 2025

Elevance Health ELV Stock Dividends
А dividend of $1.71 per share was paid with a record date of September 25, 2025, and an ex-dividend date of September 10, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of life, hospital and medical insurance plans

Industry PublishingBooksMagazines

Profile
Fundamentals
Details
Industry
Managed Health Care
Address
220 Virginia Avenue
Phone
+1 833 401-1577
Employees
104900
Web
https://www.elevancehealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EET79.780.77
+0.98%
ProShares Ultra MSCI Emerging Markets
MGC246.201.12
+0.46%
Vanguard Mega Cap ETF
SOCL60.770.21
+0.35%
Global X Social Media ETF
GENM10.300.01
+0.09%
Genter Capital Municipal Qual Interm ETF
FLHY24.41-0.01
-0.02%
Franklin High Yield Corporate ETF

ELV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELV has been closely correlated with UNH. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if ELV jumps, then UNH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELV
1D Price
Change %
ELV100%
-0.16%
UNH - ELV
79%
Closely correlated
-0.40%
MOH - ELV
73%
Closely correlated
-0.69%
CNC - ELV
70%
Closely correlated
-2.74%
HUM - ELV
61%
Loosely correlated
+4.05%
CVS - ELV
57%
Loosely correlated
-0.84%
More

Groups containing ELV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELV
1D Price
Change %
ELV100%
-0.16%
ELV
(2 stocks)
92%
Closely correlated
+1.98%
Publishing: Books/Magazines
(14 stocks)
83%
Closely correlated
+0.55%
Consumer Services
(451 stocks)
26%
Poorly correlated
+0.04%